Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Prevention of Colorectal Cancer in Patients With Rectal Polyps or Neoplasia
NCT00043043Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colorectal cancer (CRC) comparing Celecoxib with Placebo (2 arms). Primary endpoint: Number of rectal aberrant crypt foci at 6 months. Started May 2003; status: completed.
02
Drugs
celecoxib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00043043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043043.